Europe Pharmacogenomics Market (2019-2025)

日付: June 30, 2019
ページ: 103
価格:
ドル1,500.00
ライセンス[?]:
出版社: KBVリサーチ
レポートの種類: 戦略レポート
配信: メール配信(PDF)
ID: EA9F8A93B28EN
リーフレット:

PDFリーフレットをダウンロードする

Europe Pharmacogenomics Market (2019-2025)
The Europe Pharmacogenomics Market would witness market growth of 8.4% CAGR during the forecast period (2019–2025).

Pharmacogenomics is expected to facilitate the treatment of a wide spectrum of diseases such as cardiovascular diseases, Alzheimer disease, HIV/AIDS, and cancer among others. An upsurge in the investments for technology advancements is primarily poised to revolutionize the pharmacogenomics market. Furthermore, it also supports the customization of medicine doses according to a person’s genetics. This, in turn, has led to an expansion of the market presence of pharmacogenomics throughout the healthcare sector.

Improved infrastructure and technological edge in comparison to other medical centers, the advent of highly skilled medical professionals, and patients preferring hospitals over others has propelled the growth of hospitals in the end user and is anticipated to be at the top throughout the pharmacogenomics market forecast. Furthermore, research institutions are the fastest growing in the end user segment owing to the robust use of pharmacogenomics as a tool for personalized drugs for curing diseases such as cancer, several infectious diseases like tuberculosis, HIV/AIDS and others.

Based on Technology, the market is segmented into Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others. Based on Application, the market is segmented into Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others. Based on End User, the market is segmented into Hospitals and Clinics, Research Institutions, and Academic Institutes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

市場調査レポートは、市場の主要な利害関係者の分析を網羅しています。 このレポートで紹介されている主要企業には、Abbott Laboratories、Empire Genomics LLC、Illumina、oneome LLC、Myriad Genetics Inc.、Thermo Fisher Scientific、Inc。、Teva Pharmaceuticals Industries Ltd.、Bayer AG、Opko Health、およびベクトン、ディキンソンアンドカンパニー。

研究の範囲

市場セグメンテーション:

アプリケーション別
  • シーケンス
  • ポリメラーゼ連鎖反応
  • 電気泳動
  • 質量分析
  • マイクロアレイ
  • 他人
アプリケーション別
  • 腫瘍学
  • 精神医学
  • 感染症
  • 神経疾患
  • 疼痛管理
  • 心血管疾患
  • 他人
エンドユーザー別
  • 病院と診療所
  • 研究機関
  • 学術機関
国別
  • Germany
  • UK
  • France
  • ロシア
  • スペイン
  • イタリア
  • ヨーロッパの残り
プロファイル会社
  • アボット·ラボラトリーズ
  • エンパイアゲノミクスLLC
  • イルミナ株式会社
  • オネームLLC
  • 無数の遺伝学株式会社
      • サーモフィッシャーサイエンティフィック社
  • テバ製薬工業株式会社
  • Bayer AG
      • 株式会社オプコヘルス
  • ベクトン、ディキンソンアンドカンパニー
章1 市場範囲および方法論

1.1マーケット定義
1.2の目的
1.3マーケットスコープ
1.4セグメンテーション
1.4.1 Europe Pharmacogenomics Market, by Application
1.4.2 Europe Pharmacogenomics Market, by Application
1.4.3 Europe Pharmacogenomics Market, by End User
1.4.4 Europe Pharmacogenomics Market, by Country
1.5研究のための方法論

章2 市場概況

2.1はじめに
2.1.1概要
2.1.2の市場構成とシナリオ
市場に影響を与える2.2の主な要因
2.2.1マーケットドライバー
2.2.2市場の制約

CHAPTER 3. EUROPE PHARMACOGENOMICS MARKET BY TECHNOLOGY

3.1.1 Europe Sequencing Market by Country
3.1.2 Europe Polymerase Chain Reaction Market by Country
3.1.3 Europe Electrophoresis Market by Country
3.1.4 Europe Mass Spectrometry Market by Country
3.1.5 Europe Microarray Market by Country
3.1.6 Europeその他の国別市場

CHAPTER 4. EUROPE PHARMACOGENOMICS MARKET BY APPLICATION

4.1.1 Europe Oncology Market by Country
4.1.2 Europe Psychiatry Market by Country
4.1.3 Europe Infectious Diseases Market by Country
4.1.4 Europe Neurological Diseases Market by Country
4.1.5 Europe Pain Management Market by Country
4.1.6 Europe Cardiovascular Diseases Market by Country
4.1.7 Europeその他の国別市場

CHAPTER 5. EUROPE PHARMACOGENOMICS MARKET BY END USER

5.1.1 Europe Hospitals and Clinics Market by Country
5.1.2 Europe Research Institutions Market by Country
5.1.3 Europe Academic Institutes Market by Country

CHAPTER 6. EUROPE PHARMACOGENOMICS MARKET BY COUNTRY

6.1 Germany Pharmacogenomics Market
6.1.1 Germany Pharmacogenomics Market by Technology
6.1.2 Germany Pharmacogenomics Market by Application
6.1.3 Germany Pharmacogenomics Market by End User
6.2 UK Pharmacogenomics Market
6.2.1 UK Pharmacogenomics Market by Technology
6.2.2 UK Pharmacogenomics Market by Application
6.2.3 UK Pharmacogenomics Market by End User
6.3 France Pharmacogenomics Market
6.3.1 France Pharmacogenomics Market by Technology
6.3.2 France Pharmacogenomics Market by Application
6.3.3 France Pharmacogenomics Market by End User
6.4 Russia Pharmacogenomics Market
6.4.1 Russia Pharmacogenomics Market by Technology
6.4.2 Russia Pharmacogenomics Market by Application
6.4.3 Russia Pharmacogenomics Market by End User
6.5 Spain Pharmacogenomics Market
6.5.1 Spain Pharmacogenomics Market by Technology
6.5.2 Spain Pharmacogenomics Market by Application
6.5.3 Spain Pharmacogenomics Market by End User
6.6 Italy Pharmacogenomics Market
6.6.1 Italy Pharmacogenomics Market by Technology
6.6.2 Italy Pharmacogenomics Market by Application
6.6.3 Italy Pharmacogenomics Market by End User
6.7 Rest of Europe Pharmacogenomics Market
6.7.1 Rest of Europe Pharmacogenomics Market by Technology
6.7.2 Rest of Europe Pharmacogenomics Market by Application
6.7.3 Rest of Europe Pharmacogenomics Market by End User

章7 会社のプロフィール

7.1アボットラボラトリーズ
7.1.1会社の概要
7.1.2財務分析
7.1.3セグメント別および地域別分析
7.1.4研究開発費
7.1.5最近の戦略と開発:
7.1.5.1コラボレーション、パートナーシップおよび契約
7.1.5.2製品が発売されます。
7.1.5.3の買収と合併
7.1.6 SWOT分析
7.2エンパイアゲノミクスLLC
7.2.1会社の概要
7.3イルミナ株式会社
7.3.1会社の概要
7.3.2財務分析
7.3.3地域別およびセグメント分析
7.3.4研究開発費
7.3.5最近の戦略と開発:
7.3.5.1コラボレーション、パートナーシップおよび契約
7.3.5.2製品が発売されます。
7.3.5.3の買収と合併
7.4 OneOme LLC
7.4.1会社の概要
7.5 Myriad Genetics Inc.
7.5.1会社の概要
7.5.2財務分析
7.5.3セグメント別および地域別分析
7.5.4研究開発費
7.5.5最近の戦略と開発:
7.5.5.1コラボレーション、パートナーシップおよび契約
7.5.5.2製品が発売されます。
7.6サーモフィッシャーサイエンティフィック社
7.6.1会社の概要
7.6.2財務分析
7.6.3セグメント別および地域別分析
7.6.4研究開発費
7.6.5最近の戦略と開発:
7.6.5.1コラボレーション、パートナーシップおよび契約
7.6.5.2の買収と合併
7.6.6 SWOT分析
7.7テバ製薬工業株式会社
7.7.1会社の概要
7.7.2財務分析
7.7.3セグメント分析
7.7.4研究開発費
7.7.5最近の戦略と開発:
7.7.5.1製品が発売されます。
7.8バイエル社
7.8.1会社の概要
7.8.2財務分析
7.8.3セグメント別および地域別分析
7.8.4研究開発費
7.8.5最近の戦略と開発:
7.8.5.1コラボレーション、パートナーシップおよび契約
7.8.6 SWOT分析
7.9オプコヘルス株式会社(GeneDx、Inc.)
7.9.1会社の概要
7.9.2財務分析
7.9.3研究開発費
7.9.4最近の戦略と開発:
7.9.4.1コラボレーション、パートナーシップおよび契約
7.9.4.2製品が発売されます。
7.1ベクトン、ディキンソンアンドカンパニー
7.10.1会社の概要
7.10.2財務分析
7.10.3セグメント別および地域別分析
7.10.4研究開発費
7.10.5最近の戦略と開発:
7.10.5.1コラボレーション、パートナーシップおよび契約
7.10.5.2の買収と合併
7.10.5.3製品が発売されます。
7.10.6 SWOT分析

表のリスト

TABLE 1 EUROPE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 4 EUROPE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 5 EUROPE SEQUENCING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE SEQUENCING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE ELECTROPHORESIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE ELECTROPHORESIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE MASS SPECTROMETRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE MASS SPECTROMETRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE MICROARRAY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE MICROARRAY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
表15ヨーロッパその他の国別市場、2015-2018、US $ミリオン
表16ヨーロッパその他の国別市場、2019-2025、US $ミリオン
TABLE 17 EUROPE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 EUROPE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 EUROPE ONCOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE ONCOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE PSYCHIATRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE PSYCHIATRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE INFECTIOUS DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE INFECTIOUS DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
表31ヨーロッパその他の国別市場、2015-2018、US $ミリオン
表32ヨーロッパその他の国別市場、2019-2025、US $ミリオン
TABLE 33 EUROPE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 34 EUROPE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 35 EUROPE HOSPITALS AND CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 EUROPE HOSPITALS AND CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 EUROPE RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 38 EUROPE RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 39 EUROPE ACADEMIC INSTITUTES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 40 EUROPE ACADEMIC INSTITUTES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 41 EUROPE PHARMACOGENOMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 42 EUROPE PHARMACOGENOMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 43 GERMANY PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 44 GERMANY PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 45 GERMANY PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 46 GERMANY PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 47 GERMANY PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 48 GERMANY PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 49 GERMANY PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 50 GERMANY PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 51 UK PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 52 UK PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 53 UK PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 54 UK PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 55 UK PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 UK PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 UK PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 58 UK PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 59 FRANCE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 60 FRANCE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 61 FRANCE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 62 FRANCE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 63 FRANCE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 64 FRANCE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 65 FRANCE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 66 FRANCE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 67 RUSSIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 68 RUSSIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 69 RUSSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 70 RUSSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 71 RUSSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 72 RUSSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 73 RUSSIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 74 RUSSIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 75 SPAIN PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 76 SPAIN PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 77 SPAIN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 78 SPAIN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 79 SPAIN PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 80 SPAIN PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 81 SPAIN PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 82 SPAIN PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 83 ITALY PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 84 ITALY PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 85 ITALY PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 86 ITALY PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 87 ITALY PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 88 ITALY PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 89 ITALY PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 90 ITALY PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 91 REST OF EUROPE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 92 REST OF EUROPE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 93 REST OF EUROPE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 94 REST OF EUROPE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 95 REST OF EUROPE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 96 REST OF EUROPE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 97 REST OF EUROPE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 98 REST OF EUROPE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
表99の主要情報 - アボットラボラトリー
表100の主な情報-EMPIRE GENOMICS LLC
表101の主な情報–イルミナ
表102の主な情報– ONEOME LLC
表103の主な情報–ミリアドジェネティックス
表104の主な情報-THERMO FISHER SCIENTIFIC、INC。
表105の主な情報-TEVA PHARMACEUTICALS INDUSTRIES LTD。
表106の主な情報–バイエルAG
表107の主要情報-OPKO HEALTH、INC。
表108の主な情報-BECTON、DICKINSONおよびCOMPANY

図の目次

研究のためのFIG 1方法論
FIG 2 SWOT分析:ABBOTT LABORATORIES
FIG 3 SWOT分析:THERMO FISHER SCIENTIFIC、INC。
FIG 4 SWOT分析:バイエルAG
FIG 5 SWOT分析:BECTON、DICKINSONおよびCOMPANY
トップへスキップ


あなたの質問をする

Europe Pharmacogenomics Market (2019-2025)
会社名*:
連絡窓口*:
電話/ファックス*:
Eメール*:
請求書を要求する
お問い合わせ:
下のチェックボックスをクリックして、あなたがロボットではないことを確認してください。